Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, ...

All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...

China is aiming to beef up physical education in schools, making it core to the curriculum rather than a secondary subject, ...

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...

A new study uncovers a novel mechanism through which brown fat is transformed into heat, offering protection against ...

Why have drugs to treat the liver disease MASH reached a tipping point? How did Hims & Hers convince Childish Gambino to ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

Obesity has been an ongoing struggle for many consumers, and for years, body mass index (BMI) has been the key metric health ...

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.